Folate Metabolism–Based Risk Stratification Identifies CYP27B1 as a Determinant of Tumor Progression in HNSCC - Poll - MDSpire

Folate Metabolism–Based Risk Stratification Identifies CYP27B1 as a Determinant of Tumor Progression in HNSCC

  • By

  • Kai, Zhang

  • Hu, Haixia

  • Liu, Bingya

  • April 21, 2026

  • 0 min

Share

Original Source(s)

Folate Metabolism–Based Risk Stratification Identifies CYP27B1 as a Determinant of Tumor Progression in HNSCC

  • by Kai, Zhang , Hu, Haixia , Liu, Bingya

  • April 21, 2026

Related Content

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

High-grade astrocytoma with piloid features: a case report of comprehensive management

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities